Nu-Med Plus, Inc. (NUMD) Research

Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.

Market snapshot

Symbol
NUMD
Price
$0.01
Day change
0.00%
Market cap
$793.7K
P/E ratio
-15.23x
52-week range
0.0095-0.05
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Binovi Technologies Corp. (BNVIF)
  • Cryomass Technologies Inc. (CRYM)
  • Costas, Inc. (CSSI)
  • Kelyniam Global, Inc. (KLYG)
  • Medical Supply International USA, Inc. (MSIU)
  • Polarean Imaging plc (PLLWF)
  • Regional Health Properties, Inc. (RHEP)
  • Reliq Health Technologies Inc. (RQHTF)

Recent insider activity

  • MERRELL KEITH L — trade (0 shares) on 2015-08-01
  • Robins Jeffrey Lynn — A-Award (200000 shares) on 2023-11-07
  • HAYDE WILLIAM C — A-Award (1000000 shares) on 2023-11-07
  • HAYDE WILLIAM C — trade (0 shares) on 2022-09-12
  • Smith Wendy P. — trade (0 shares) on 2021-03-02

Open Nu-Med Plus, Inc. (NUMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.